The Importance of the Van Nuys Prognostic Index in Ductal Carcinoma in Situ Management
Author Information
Author(s): Gilleard Onur, Goodman Andrew, Cooper Martin, Davies Mary, Dunn Julie
Primary Institution: The Royal Devon and Exeter Breast Cancer Unit
Hypothesis
The Van Nuys Prognostic Index (VNPI) can help identify patients with ductal carcinoma in situ (DCIS) who are at increased risk of local recurrence and may benefit from adjuvant radiotherapy.
Conclusion
The VNPI is a significant predictor of local recurrence in patients with DCIS treated with local excision alone, suggesting its utility in guiding treatment decisions regarding radiotherapy.
Supporting Evidence
- The study included 215 patients treated with local excision and observation alone.
- The observed 8-year disease-free survival rate was 91%, while the actuarial rate was 83%.
- The VNPI score was found to be a statistically significant prognostic indicator.
Takeaway
Doctors can use a scoring system called the Van Nuys Prognostic Index to figure out which patients with a type of breast cancer called DCIS might need extra treatment to prevent the cancer from coming back.
Methodology
A retrospective review of 215 patients who underwent breast conserving surgery for DCIS, with analyses including Kaplan Meier survival curves and Cox regression.
Potential Biases
The retrospective nature of the study may lead to selection bias and confounding factors not being controlled.
Limitations
The study is retrospective, which may introduce bias, and the follow-up period may not be long enough to capture all recurrences.
Participant Demographics
Mean age at diagnosis was 60.3 years, with a range from 33 to 91 years.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website